Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.

Allergopharma

Status and phase: Completed; Phase 4

Conditions: Type I Allergy

Treatments: Other: Skin Prick Test

Study type: Interventional

Funder types: Industry

Identifiers

NCT00665483

AL0205PR

2006-005304-14 (EudraCT Number)

Details and patient eligibility

About

Multicenter Skin Prick Test

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• anamnesis referring to suspicion of an IgE-mediated allergy
• positive Skin Prick Test in the medical history to at least one of the investigational allergens with an existing anamnesis

Exclusion criteria

• serious chronic diseases
• Other perennial allergies

Trial design

0 participants in 1 patient group

1

Experimental group

Description:

Skin Prick Test

Treatment:

Other: Skin Prick Test